Active Ingredient: SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
Proprietary Name: VOSEVI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG;100MG;100MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209195
Product Number: 001
Approval Date: Jul 18, 2017
Applicant Holder Full Name: GILEAD SCIENCES INC
Marketing Status:
Prescription
Patent and Exclusivity Information
